RETNLB and inflammation: While Retn1a (also known as FIZZ-1) has been identified as a critical regulator of allergic inflammation [19,20], Samarasinghe and colleagues [21] reported that the direct administration of recombinant Retnla and Retnlb to the airways resulted in a significant reduction in host immune responses in mice infected with influenza A.